These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2891473

  • 1. The disposition and metabolism of 2',3'-dideoxycytidine, an in vitro inhibitor of human T-lymphotrophic virus type III infectivity, in mice and monkeys.
    Kelley JA, Litterst CL, Roth JS, Vistica DT, Poplack DG, Cooney DA, Nadkarni M, Balis FM, Broder S, Johns DG.
    Drug Metab Dispos; 1987; 15(5):595-601. PubMed ID: 2891473
    [Abstract] [Full Text] [Related]

  • 2. Disposition in animals of a new anti-HIV agent: 2',3'-didehydro-3'-deoxythymidine.
    Russell JW, Whiterock VJ, Marrero D, Klunk LJ.
    Drug Metab Dispos; 1990; 18(2):153-7. PubMed ID: 1971565
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and metabolism of 3'-azido-2',3'-dideoxy-5-methylcytidine in rhesus monkeys.
    Boudinot FD, Schinazi RF, Doshi KJ, McClure HM, Chu CK.
    Drug Metab Dispos; 1993; 21(5):855-60. PubMed ID: 7902248
    [Abstract] [Full Text] [Related]

  • 4. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
    Vincent SH, Painter SK, Luffer-Atlas D, Karanam BV, McGowan E, Cioffe C, Doss G, Chiu SH.
    Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
    [Abstract] [Full Text] [Related]

  • 5. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH, Painter SK, Krieter PA, Colletti AE, Lyszack E, Rosegay A, Dean D, Luffer-Atlas D, Miller RR, Cioffe C, Chiu SH.
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [Abstract] [Full Text] [Related]

  • 6. Disposition and metabolism of carbovir in mice dosed intravenously or orally.
    el Dareer SM, Tillery KF, Rose LM, Struck RF, Hill DL.
    Drug Metab Dispos; 1990 Dec; 18(6):842-5. PubMed ID: 1981526
    [Abstract] [Full Text] [Related]

  • 7. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J, Cooney DA, Dalal M, Kang GJ, Cupp JE, DeClercq E, Broder S, Johns DG.
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
    Siefert HM, Maruhn D, Maul W, Förster D, Ritter W.
    Arzneimittelforschung; 1986 Oct; 36(10):1496-502. PubMed ID: 3814211
    [Abstract] [Full Text] [Related]

  • 10. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog.
    Kaul S, Shyu WC, Shukla UA, Dandekar KA, Barbhaiya RH.
    Drug Metab Dispos; 1993 Oct; 21(3):447-53. PubMed ID: 8100500
    [Abstract] [Full Text] [Related]

  • 11. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
    Colletti AE, Krieter PA.
    Drug Metab Dispos; 1994 Oct; 22(2):183-8. PubMed ID: 8013272
    [Abstract] [Full Text] [Related]

  • 12. Metabolism and disposition of a thiazolobenzimidazole active against human immunodeficiency virus-1.
    el Dareer SM, Tillery KF, Rose LM, Posey CF, Struck RF, Stiller SW, Hill DL.
    Drug Metab Dispos; 1993 Oct; 21(2):231-5. PubMed ID: 8097690
    [Abstract] [Full Text] [Related]

  • 13. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS, Hatch HL, Kosea F, Nguyen HT, Choo EF, McClure KF, Taylor TJ, Henne KR, Kuperman AV, Dombroski MA, Letavic MA.
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic disposition of guanabenz in the rhesus monkey.
    Meacham RH, Chiang ST, Kick CJ, Sisenwine SF, Jusko WJ, Ruelius HW.
    Drug Metab Dispos; 1981 Nov; 9(6):509-14. PubMed ID: 6120807
    [Abstract] [Full Text] [Related]

  • 15. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of the antiviral agent beta-D-2'-deoxy-2'-fluoro-2'-C-methylcytidine in rhesus monkeys.
    Asif G, Hurwitz SJ, Shi J, Hernandez-Santiago BI, Schinazi RF.
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2877-82. PubMed ID: 17562805
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.